Cassia Cearley Ph.D.
Net Worth

Last updated:

What is Cassia Cearley Ph.D. net worth?

The estimated net worth of Ms. Cassia Cearley Ph.D. is at least $2,016,900 as of 20 Dec 2023. She has earned $619,900 from insider trading and has received compensation worth at least $1,397,000 in Icosavax, Inc..

What is the salary of Cassia Cearley Ph.D.?

Ms. Cassia Cearley Ph.D. salary is $349,250 per year as Treasurer & Chief Bus. Officer in Icosavax, Inc..

How old is Cassia Cearley Ph.D.?

Ms. Cassia Cearley Ph.D. is 43 years old, born in 1982.

What stocks does Cassia Cearley Ph.D. currently own?

As insider, Ms. Cassia Cearley Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Icosavax, Inc. (ICVX) Treasurer & Chief Bus. Officer 130,694 $0 $0

What does Icosavax, Inc. do?

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

ICVX logo
ICVX
Icosavax, Inc.

Cassia Cearley Ph.D. insider trading

Icosavax, Inc.

Ms. Cassia Cearley Ph.D. has made 11 insider trades between 2021-2023, according to the Form 4 filled with the SEC. Most recently she sold 7,934 units of ICVX stock worth $122,636 on 20 Dec 2023.

The largest trade she's ever made was exercising 35,137 units of ICVX stock on 18 Mar 2022. As of 20 Dec 2023 she still owns at least 130,694 units of ICVX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,934 $15.46 $122,636
Sale
Common Stock 8,759 $16.01 $140,188
Sale
Common Stock 1,888 $8.86 $16,731
Sale
Common Stock 10,000 $10 $100,000
Sale
Common Stock 5,000 $7.75 $38,735
Sale
Common Stock 1,660 $10.69 $17,750
Option
Stock Option (Right to Buy) 25,102 $0.84 $21,086
Option
Common Stock 25,102 $0.84 $21,086
Sale
Common Stock 303 $6.7 $2,031
Sale
Common Stock 1,118 $6.64 $7,420
Sale
Common Stock 391 $7.11 $2,779
Option
Stock Option (Right to Buy) 35,137 $0.84 $29,515
Option
Common Stock 35,137 $0.84 $29,515
Sale
Common Stock 9,516 $17.13 $163,009
Sale
Common Stock 484 $17.81 $8,620
Option
Common Stock 22,598 $0.83 $18,756
Option
Stock Option (Right to Buy) 22,598 $0.83 $18,756

Icosavax key executives

Icosavax, Inc. executives and other stock owners filed with the SEC:

  • Mr. Adam K. Simpson (50) Pres, Chief Executive Officer & Director
  • Mr. Douglas A. Holtzman M.P.H., Ph.D. (61) Chief Scientific Officer & Sec.
  • Mr. Niranjan Kanesa-thasan M.D. (65) Chief Medical Officer
  • Ms. Cassia Cearley Ph.D. (43) Treasurer & Chief Bus. Officer